- Home
- JRI
JRI
Nuveen Real Asset Income and Growth Fund of Beneficial Interest
as 12-18-2024 9:38am EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 68.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $9.70 - $12.12 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Nuveen Real Asset Income and Growth Fund of Beneficial Interest News
JRI Breaking Stock News: Dive into JRI Ticker-Specific Updates for Smart Investing
PR Newswire
a month ago
With $500 Million Total Allocation from CalPERS, Nuveen Underscores Commitment to Preserve Affordable Housing and Build Resilient Communities
Business Wire
7 months ago
Nuveen Closed-End Funds Announce Leading Independent Proxy Advisory Firm, Glass Lewis, Fully Supports Nuveen’s Board Nominees
PR Newswire
8 months ago
Nuveen Announces Closing of $1.25 Billion Senior Notes Offering
Business Wire
10 months ago
Nuveen Real Asset Income and Growth Fund Announces Update to Portfolio Management Team
Insider Monkey
a year ago
30 Best Cardiology Hospitals In the US
Simply Wall St.
a year ago
Should You Investigate Universal Technical Institute, Inc. (NYSE:UTI) At US$15.19?
Simply Wall St.
a year ago
Liberty Energy Inc. (NYSE:LBRT) Annual Results: Here's What Analysts Are Forecasting For This Year
Barrons.com
a year ago
Manufacturing Activity in Central U.S. Drops Sharply at Start of Year
Compare JRI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.